Financial Data and Key Metrics Changes - The company reported total revenues of $239.7 million for the second quarter, a 14.7% increase compared to $209 million in the same quarter of fiscal year 2025 [21] - Adjusted EBITDA was $22.2 million, compared to $5.9 million in the second quarter of fiscal year 2025, achieving an adjusted EBITDA margin of 9.2% [26][27] - Net income for the quarter was $11.8 million, a significant improvement from a net loss of $13.5 million in the second quarter of fiscal year 2025 [26] Business Line Data and Key Metrics Changes - The company served approximately 8,010 participants across 20 centers, reflecting a growth of 7.1% year-over-year [19] - Member months totaled 23,960, marking a 7.9% increase compared to the second quarter of fiscal year 2025 [20] - The central level contribution margin was $52.8 million, representing 22% of total revenues, an increase of approximately 430 basis points from 17.7% in the same quarter last year [24] Market Data and Key Metrics Changes - The company experienced a favorable blended rate environment for Medicaid this fiscal year, which was better than initial assumptions [10] - The Medicare Advantage rates for calendar year 2027 were discussed, indicating that changes in these rates will affect the company's PACE model [11] Company Strategy and Development Direction - The company is focused on improving participant experience and operational efficiency, with initiatives aimed at reducing unwarranted variation in provider practice patterns [13][60] - There is a commitment to enhancing governance structures to support the next phase of execution and oversight [15] - The company is raising its full-year fiscal 2026 guidance based on improved operational performance and Medicaid rate increases [17][31] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the company's ability to sustain performance improvements, emphasizing the importance of disciplined execution and long-term planning [17][31] - The company acknowledged ongoing challenges related to Medicaid redeterminations but noted significant progress in reinstating participants who had lost coverage [36][48] Other Important Information - The company ended the quarter with $83.2 million in cash and cash equivalents and $42.8 million in short-term investments [29] - De novo losses for the quarter were reported at $4.7 million, primarily related to new centers in Florida [27] Q&A Session Summary Question: Regarding EBITDA progression in the back half of the year - Management noted that the third quarter is typically softer due to seasonal factors and the flu season, which may impact margins [34][35] Question: Impact of V28 on risk scores - Management indicated that while there are challenges with the new risk adjustment model, the company is structurally less exposed compared to other Medicare Advantage plans [39] Question: Success in Medicaid redeterminations - Management highlighted improvements in internal processes and collaboration with state-level processes, leading to better outcomes in reinstating Medicaid coverage [46][48] Question: Participant experience and retention - Management discussed the importance of aligning participant expectations with their experiences to reduce voluntary disenrollment, which currently stands at about 6% annually [57][65]